Illumina Accelerator portfolio grows to 68 startups 93% of graduate companies successfully secured additional capital SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, UK. The global company creation engine is focused on partnering with entrepreneurs to [...]

BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. Dr. Ma is Chief Executive Officer, founder, and a director of PrognomiQ, a privately held healthcare company that is developing next-generation, transformative multiomics products to enable [...]

Gibco CTS Xenon Electroporation System complements Thermo Fisher Scientific’s portfolio of end-to-end cell therapy solutions CARLSBAD, Calif. – Thermo Fisher Scientific, the world leader in serving science, has introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages [...]

Partnership will expand use of next-generation sequencing (NGS) to help diagnose patients quickly and more accurately. NEW DELHI - Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) and Trivitron Healthcare, one of India's largest medical technology companies, have entered into a strategic partnership to develop and expand the use of next-generation sequencing (NGS)-based in-vitro diagnostic tests (IVD) [...]

Launch marks product’s first use in a commercial therapeutic SUNNYVALE, California – JSR Life Sciences, LLC today announced that its lead product, Amsphere™ A3 has been incorporated for the first time into the commercial manufacturing of an FDA-approved treatment. Amsphere™ A3 is a next generation Protein-A chromatography resin that enables advanced protein separation in downstream processing [...]

Experienced Product and Operations Leader to Accelerate Delivery of Ambitious Roadmap in Single Cell Genomics SAN DIEGO, Calif. and CAMBRIDGE, UK -- CS Genetics, a privately held genomics-technology company, today announced the appointment of Jay Harger, PhD, as Senior Vice President of Operations. Jay will lead a variety of critical company operations including facilities, manufacturing [...]

 The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the specific molecular profile [...]

Hamburg -- Eppendorf has made a strategic investment in BigOmics Analytics SA, a software company from Switzerland that develops digital cloud-based self-service tools to analyze molecular biology research data. “We’re excited to invest in BigOmics,” said Peter Fruhstorfer, Co-CEO of Eppendorf SE, upon signing the agreement. “With its expertise and digital know-how, the company is [...]

Growing portfolio of chemicals part of a larger quality management system that sets new standards in bioprocessing GARDENA, CA -- Spectrum Chemical Mfg. Corp, a leading global provider of fine chemicals, laboratory equipment and supplies, announced today it has added 12 new products to its rapidly growing bioCERTIFIED™ quality management system and chemicals portfolio for biopharmaceutical [...]

Biognosys’ TrueSignature™ proteomics panels serve as pharmacodynamic readout for protein degradation in Kymera’s discovery and clinical trial programs ZURICH -- Biognosys AG, a leader in next-generation proteomics solutions for drug discovery and development, and Kymera Therapeutics, a clinical-stage biopharmaceutical company advancing targeted protein degradation (TPD), announced today that they are broadly collaborating across preclinical studies and [...]